Development of a macromolecular prodrug of FK506: I. Synthesis of FK506-dextran conjugate

被引:1
|
作者
Yura, H
Yoshimura, N
Hamashima, T
Oka, T
Takakura, Y
Hashida, M
机构
[1] Kyoto Prefectural Univ Med, Dept Surg 2, Kamigyo Ku, Kyoto, Japan
[2] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 606, Japan
关键词
D O I
10.1016/S0041-1345(98)01153-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:3598 / 3599
页数:2
相关论文
共 50 条
  • [21] TAUTOMERIC PHENOMENON OF FK506 IN SOLUTION
    NAMIKI, Y
    KIHARA, N
    FUJIOKA, M
    SHIMATANI, K
    FUJIWARA, A
    HANE, K
    YASUDA, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 72 - ANYL
  • [22] CSA AND FK506 REGULATION OF CYTOKINES
    NGUYEN, D
    DEFORGE, L
    REMICK, D
    FASEB JOURNAL, 1991, 5 (06): : A1638 - A1638
  • [23] CMV RETINITIS AND IMMUNOSUPPRESSION WITH FK506
    FRIBERG, TR
    PAUL, AA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 751 - 751
  • [24] Interaction of FK506 with antizyme inhibitor
    Mangold, U
    Musicki, B
    Ohage, S
    Wendler, W
    Kirschbaum, B
    Leberer, E
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 242A - 242A
  • [25] FK506与心脏移植
    孟旭
    陈宝田
    中华胸心血管外科杂志, 1998, (02) : 58 - 60
  • [26] Behavioral assessment of neuroprotection by FK506
    Marston, HM
    Sharkey, J
    IMMUNOPHILINS IN THE BRAIN: FKBP LIGANDS: NOVEL STRATEGIES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS, 2000, : 173 - 182
  • [27] ORAL ABSORPTION OF FK506 IN RATS
    KAGAYAMA, A
    TANIMOTO, S
    FUJISAKI, J
    KAIBARA, A
    OHARA, K
    IWASAKI, K
    HIRANO, Y
    HATA, T
    PHARMACEUTICAL RESEARCH, 1993, 10 (10) : 1446 - 1450
  • [28] The mechanism of action of cyclosporin A and FK506
    Ho, S
    Clipstone, N
    Timmermann, L
    Northrop, J
    Graef, I
    Fiorentino, D
    Nourse, J
    Crabtree, GR
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 80 (03): : S40 - S45
  • [29] Stability of FK506 in blood samples
    Alak, AM
    Lizak, P
    THERAPEUTIC DRUG MONITORING, 1996, 18 (02) : 209 - 211
  • [30] Comparison of FK506 and cyclosporine - Reply
    Gjertson, DW
    Cecka, JM
    TRANSPLANTATION, 1996, 62 (05) : 702 - 702